StopDownOpen the app

Funding · Healthcare & Life Sciences

Rymo Technologies raises ₹10 crore seed funding

By ·

Date
Company
Rymo Technologies
What it does
Robotic neuro-rehabilitation devices
Kind
Funding
Amount
₹10 Cr
Stage
seed
Based in
Navi Mumbai
Founded
2020
Sector
Healthcare & Life Sciences

What they do

Rymo Technologies makes robotic systems for neuro-rehabilitation with AI therapy personalisation

What happened

It raised over ₹10 crore in seed funding led by IAN Angel Fund

Why it matters

The company has installed over 452 devices and served more than 7,500 patients

The details

  • Rymo Technologies raised over ₹10 crore in seed funding.
  • The round was led by IAN Angel Fund, the evergreen fund of the IAN Group.
  • Other angel investors also participated in the round.
  • The company will use the funds to accelerate product innovation and expand manufacturing.
  • It also plans to strengthen its presence in India and scale into ASEAN and the Middle East.
  • Rymo has a distribution partnership with Fourier Rehab for ASEAN markets.

The bigger picture

  • The global neuro-rehabilitation devices market is valued at about $2.16 billion and growing roughly 14% annually.
  • Rymo's devices have shown up to 25% faster recovery outcomes per studies.
  • The company has received US FDA Class II medical device classification.
  • A clinical validation study is underway in Italy.

About the business

  • Rymo Technologies is a robotic neuro-rehabilitation startup headquartered in Navi Mumbai, India.
  • Its product is a multi-joint robotic rehabilitation system with AI-driven therapy personalisation.
  • The flagship product is the Mobi-L system.
  • Target customers include mid-sized hospitals and physiotherapy clinics in Tier 1 and Tier 2 cities.
  • It has installed over 452 devices across 354 clinical customers, including AIIMS, Apollo Hospitals, and Manipal Hospitals.
  • The platform has supported over 7,500 patients and delivered over 15,000 therapy hours.

What happens next

  • Accelerate product innovation.
  • Expand manufacturing capabilities.
  • Strengthen India presence.
  • Scale into ASEAN and Middle East markets.

The deal

Type
seed

Investors

Founders

  • Chirag Shah, CEO
  • Abhishek Rai, CTO

About Rymo Technologies

Product
Robotic neuro-rehabilitation systems including flagship Mobi-L device with VR integration for post-stroke and neurological recovery
Customers
Patients recovering from strokes, injuries and neurological conditions; rehabilitation centers and hospitals
How it makes money
B2B2C medical device sales and installation with ongoing support
What sets it apart
Accessible and affordable advanced rehabilitation technology addressing gap in neuro-rehabilitation access

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 19 March 2026 →